Ananiti-malaria drug touted by President Trump as a"game changer" for COVID-19 showed no benefit, according to an analysis of patients hospitalized in Veterans Health Administration medical centers.
The analysis found the two primary outcomes for people treated with hydroxychloroquine were death and the need for mechanical ventilation.
The analysis was conducted retrospectively, based on data from patients hospitalized with confirmed COVID-19 infections in all VA medical centers until April 11, 2020.
TVNL Comment: Read the second paragraph carefully. Self-anointed Dr. Trump is a charleton.
Six people were injured, and a suspect is in custody on June 7 after stabbings were...
The images coming out of Moscow in recent days speak for themselves: Ukrainian drone strikes on...
A sinkhole was discovered at New York’s LaGuardia airport on Wednesday, shutting down a runway while...
